Obesity

Weight loss drugs have become a central tool in treating obesity, including among adolescents, but alongside the medical success, worrying evidence of the development of eating disorders following rapid weight loss is beginning to emerge. Experts warn that precisely when the weight appears normal, dangerous medical and psychological signs may be hidden, requiring close monitoring and special...

Donald Trump has gained about 10 kilograms since his last campaign and currently weighs about 108 kg, less than a kilogram away from the definition of obesity. Doctors warn of the risks, while the White House emphasizes that the 80-year-old president is in "excellent health."

The attraction to high-fat foods is not necessarily just a matter of willpower: a new study from Osaka Metropolitan University in Japan has identified a brain mechanism that may influence fat consumption and body weight. The researchers found that damaging a mitochondrial protein called OPA1 in nerve cells associated with appetite regulation caused mice to consume more fat and gain weight.

While many struggle with weight-loss medications, a new study reveals that there is a much easier method that can easily shed excess kilograms from the body. The mechanism is not a "fat-burning" magic, but a combination of caloric savings and a slight, temporary increase in energy expenditure.

Data from Maccabi Healthcare Services reveals a troubling trend: about 50% of adults live with overweight or obesity, with 23% classified as obese, while 26% of children also struggle with weight issues.

Professor Roi Eldor, director of the Endocrinology Institute at the Tel Aviv Sourasky Medical Center (Ichilov), discussed the benefits of weight loss injections on 103FM, emphasizing the necessity of proper medical guidance.

New studies raise the possibility that drugs from the GLP-1 family, used to treat obesity and diabetes, may reduce the risk of breast cancer recurrence. However, at this stage, these are observational findings only.

Eli Lilly is launching an early access program for Retatrutide, a promising weight-loss drug that has shown record-breaking results in clinical trials. The move follows concerns over a black market for counterfeits.

The use of weight loss medications like Ozempic, Wegovy, and Mounjaro raises questions for women of reproductive age. A new international consensus document published in Obesity Reviews provides the first practical guidelines for patients and doctors.

The doctor and media personality addressed the thriving weight-loss drug industry on his 103FM radio show and presented data from a new clinical trial. Alongside the impressive results, he emphasizes the central problem: "When people stop because of side effects – it is cause for concern."